Findoc-cll.in/1st_qtr_result

COLINZ LABORATORIES LIMITED
A-101, Pratik Ind. Estate, Next to Fortis Hospital, Mulund-Goregaon Link Road, Mumbai - 400 078.

UN-AUDITED FINANCIAL RESULTS FOR QUATERS ENDED 30TH JUNE 2011

				(Rupees in '000')
S. No.	Particulars	Un -audited		Audited
		Quarter Ended	Quarter Ended	Year Ended
		30.06.2011	30.06.2010	31.03.2011
1.	Net Sales	2,19,72	1,75,78	6,03,36
2.	Other Income	29	43	2,22
3.	Total Income	2,20,01	1,76,21	6,05,58
4.	Total Expenditure
	(a) Increase/ Decrease in Stock in Trade	44,26	- 3,79	-23,11
	(b) Consumption of Materials	69,25	86,09	2,40,79
	(c) Excise Duty	7,97	5,66	33,13
	(d) Staff Cos	41,43	36,96	1,50,94
	(e) Other Expenditure	43,37	39,50	1,54,60
5.	Profit before Interest. Depreciation and Taxation	13,73	11,79	49,23
6.	Interest	4,10	3,45	15,61
7.	Depreciation	6,44	6,43	25,77
8.	Profit Before Tax	3,19	1,91	7,85
9.	Provision for Current Tax	-	-	1,34
10.	Provision for Deferred Tax	-	-	(78)
11.	Fringe Benefit Tax	-	-	-
12.	Net Profit afterTax	3,19	1,91	7,29
13.	Paid up Equity Share Capital [Net of allotment money in arrears]	3,54,35	3,54,35	3,54,35
14.	Reserves Excluding Revaluation Reserves Less Deferred Tax Provision	-	-	65,26
15.	E. P. S.	-	-	0.16
16.	Aggregate of non promoter share -holding. Aggregate of non promoter share -holding. No. of shares -Percentages of shareholding	29,02,900 63.51%	28,99,900 63.44%	29,02,900 63.51%
17.	Promoters and promoter group Shareholding a) Pledged/Encumbered - Number of shares	-	-	-
	- Percentage of shares (as a % of the total shareholding of promoter and promoter group)	-	-	-
	- Percentage of shares (as a% of the total share capital of the company)	-	-	-
	b) Non-encumbered - Number of Shares	16,68,100	16,71,100	16,68,100
	- Percentage of shares (as a% of the total shareholding of promoter and promoter group)	100%	100%	100%
	- Percentage of shares (as a % of the total share capital of the company)	36.49%	36.56%	36.49%

(Rupees in ‘ 000)
STATEMENT OF ASSETS AND LIABILITES
	As on 30.06.2011 (Un-Audited)	As on 30.03.2011 (Audited)
CAPITAL & LIABILITIES
Capital Reserve and Surplus Secured Loan Other Liabilities Total	3,54,35 2,86,49 72,84 1,54,19 8,67,87	3,54,35 2,83,30 1,30,84 1,53,83 9,22,32
ASSETS
Investment Fixed Assets Net Current Assets Total	31,59 4,34,86 4,01,42 8,67,87	31,59 4,41,31 4,49,42 9,22,32

NOTES :-

The above results subjected to ‘Limited Review’ by the Auditors of the Company, were taken on record by the Board of Directors of the Company, at their meeting held on
30.07.2011
The Un-audited results for the quarter do not reflect the trend for the year.
Income Tax provision, whatever found necessary, will be considered at the end of the year
The company operates in single segment of manufacture of pharmaceutical formulations. Hence Accounting Standard on segment reporting is not applicable
The Company did not have any investors’ complaint pending at the beginning of the quarter. No investors’ complaints were received during the quarter and hence no investors’ complaints remained unsolved at the end of the quarter ended 30-06-2011.